BIOMAT Database Logo BIOMAT Database Logo

A human cell line of chronic myelogenous leukemia releasing a novel virus-like particle. 1988

T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012190 Retroviridae Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES). Leukemogenic Viruses,Leukoviruses,Oncornaviruses,Oncovirinae,Oncoviruses,Oncoviruses, Type C,RNA Tumor Viruses,Retroviruses,Type C Oncoviruses,C Oncovirus, Type,C Oncoviruses, Type,Leukemogenic Virus,Leukovirus,Oncornavirus,Oncovirus,Oncovirus, Type C,RNA Tumor Virus,Retrovirus,Tumor Virus, RNA,Tumor Viruses, RNA,Type C Oncovirus,Virus, Leukemogenic,Virus, RNA Tumor,Viruses, Leukemogenic,Viruses, RNA Tumor
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.
March 1975, Blood,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line.
December 1994, Blood,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Induction of erythropoietic colonies in a human chronic myelogenous leukemia cell line.
November 1979, Blood,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Lineage infidelity of a human myelogenous leukemia cell line.
November 1984, Blood,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Human granulocyte antigens detected on leukemia cells and a chronic myelogenous cell line.
January 1978, Vox sanguinis,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
May 1990, Leukemia,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line.
February 2018, Anti-cancer agents in medicinal chemistry,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Human immunodeficiency virus Infection in a patient of chronic myelogenous leukemia.
October 2013, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
Transport of ribavirin in human myelogenous leukemia cell line K562.
July 2020, Die Pharmazie,
T Tange, and I Yamasaki, and K Nakahara, and H Nakauchi, and M Hayami, and F Tanaka, and K Mitani, and S Fujioka, and R Takanashi, and T Yoshino
[Transcriptome Analysis of Chronic Myelogenous Leukemia Cell Line with Imatinib Resistance].
December 2021, Zhongguo shi yan xue ye xue za zhi,
Copied contents to your clipboard!